tm
Seeing Is Believing
tm
Seeing Is Believing
MTNB is currently covered by 1 analysts with an average price target of $44. This is a potential upside of $42.4 (2650%) from yesterday's end of day stock price of $1.6.
Matinas BioPharma Holdings's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of MTNB is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 525 days.
Highest price target for MTNB is $1, Lowest price target is $1.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 31-Oct-2024. First documented stock forecast 21-Nov-2016.
Currently out of the existing stock ratings of MTNB, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
11 months 23 days ago
(31-Oct-2024)
0/1 (0%)
$123 (159.74%)
Buy
$90
4 years 5 months 13 days ago
(11-May-2021)
0/1 (0%)
$3 (3.45%)
Hold
$2
4 years 5 months 14 days ago
(11-May-2021)
2/2 (100%)
$1.2 (150.00%)
1575
What is MTNB (Matinas BioPharma Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?
Which analyst has the current lower performing score on MTNB (Matinas BioPharma Holdings) with a proven track record?
Which analyst has the most public recommendations on MTNB (Matinas BioPharma Holdings)?
Which analyst is the currently most bullish on MTNB (Matinas BioPharma Holdings)?
Which analyst is the currently most reserved on MTNB (Matinas BioPharma Holdings)?
